RT Journal Article
SR Electronic
T1 Uncertainty and error in SARS-CoV-2 epidemiological parameters inferred from population-level epidemic models
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2022.07.01.22277134
DO 10.1101/2022.07.01.22277134
A1 Dominic G. Whittaker
A1 Alejandra D. Herrera-Reyes
A1 Maurice Hendrix
A1 Markus R. Owen
A1 Leah R. Band
A1 Gary R. Mirams
A1 Kirsty J. Bolton
A1 Simon P. Preston
YR 2022
UL http://medrxiv.org/content/early/2022/07/02/2022.07.01.22277134.abstract
AB During the SARS-CoV2 pandemic, epidemic models have been central to policy-making. Public health responses have been shaped by model-based projections and inferences, especially related to the impact of various non-pharmaceutical interventions. Accompanying this has been increased scrutiny over model performance, model assumptions, and the way that uncertainty is incorporated and presented. Here we consider a population-level model, focusing on how distributions representing host infectiousness and the infection-to-death times are modelled, and particularly on the impact of inferred epidemic characteristics if these distributions are misspecified. We introduce an SIR-type model with the infected population structured by ‘infected age’, i.e. the number of days since first being infected, a formulation that enables distributions to be incorporated that are consistent with clinical data. We show that inference based on simpler models without infected age, which implicitly misspecify these distributions, leads to substantial errors in inferred quantities relevant to policy-making, such as the reproduction number and the impact of interventions. We consider uncertainty quantification via a Bayesian approach, implementing this for both synthetic and real data focusing on UK data in the period 15 Feb–14 Jul 2020, and emphasising circumstances where it is misleading to neglect uncertainty.Competing Interest StatementDGW is now employed by GlaxoSmithKline Plc. There are no other competing interests.Funding StatementThis work was supported by the Wellcome Trust [grant number 212203/Z/18/Z]. DGW, ADH-R and GRM acknowledge support from the Wellcome Trust via a Senior Research Fellowship to GRM. KJB acknowledges support from a University of Nottingham Anne McLaren Fellowship. This research was funded in whole, or in part, by the Wellcome Trust [212203/Z/18/Z]. For the purpose of open access, the author has applied a CC-BY public copyright licence to any Author Accepted Manuscript version arising from this submission.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesOpen source software to reproduce the results in this paper is available at https://github.com/DGWhittaker/nottingham_covid_modelling https://github.com/DGWhittaker/nottingham_covid_modelling